Brooks Automation, Inc. (BRKS) Income Statement Analysis

See more : Brunello Cucinelli S.p.A. (BC.MI) Income Statement Analysis – Financial Results

Complete financial analysis of Brooks Automation, Inc. (BRKS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Brooks Automation, Inc., a leading company in the Semiconductors industry within the Technology sector.

You may be interested

Brooks Automation, Inc. (BRKS)

Industry: Semiconductors

Sector: Technology

Website: http://www.brooks.com

About Brooks Automation, Inc.

Brooks Automation, Inc. provides automation and cryogenic solutions worldwide. The company operates in two segments, Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers wafer automation and contamination controls solutions and services. Its products include atmospheric and vacuum robots, robotic modules, and tool automation systems that offer precision handling and clean wafer environments; and automated cleaning and inspection systems for wafer carriers, reticle pod cleaners, and stockers. This segment also offers repair, diagnostic, and installation services, as well as spare parts and productivity enhancement upgrade services. The Brooks Life Science Systems segment provides automated cold storage systems; consumables, including various formats of racks, tubes, caps, plates, and foils; and instruments used for labeling, bar coding, capping, de-capping, auditing, sealing, peeling, and piercing tubes and plates. It also provides sample management services, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery, and business continuity, as well as project management and consulting. In addition, this segment offers sample intelligence software solutions and customer technology integration; laboratory work flow scheduling for life science tools and instrument work cells, sample inventory and logistics, environmental and temperature monitoring, and clinical trial and consent management, as well as planning, data management, virtualization, and visualization services; and gene sequencing analysis and synthesis services. The company serves the semiconductor capital equipment and life sciences sample management markets in approximately 50 countries. Brooks Automation, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Metric	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994
Revenue	513.70M	897.27M	780.85M	631.56M	692.89M	560.32M	552.71M	482.85M	450.95M	519.45M	688.11M	592.97M	218.71M	526.37M	743.26M	692.87M	463.75M	539.77M	343.61M	304.25M	381.72M	321.10M	103.90M	99.90M	86.40M	90.40M	45.70M	24.00M
Cost of Revenue	269.89M	517.25M	464.59M	385.48M	425.48M	362.24M	363.60M	315.51M	304.97M	345.97M	465.08M	426.68M	224.70M	399.54M	523.66M	448.09M	300.94M	335.45M	239.94M	221.21M	229.33M	159.66M	47.80M	64.30M	53.60M	49.50M	26.10M	14.20M
Gross Profit	243.81M	380.02M	316.26M	246.08M	267.40M	198.08M	189.11M	167.34M	145.98M	173.49M	223.02M	166.30M	-6.00M	126.83M	219.60M	244.78M	162.80M	204.32M	103.67M	83.04M	152.38M	161.44M	56.10M	35.60M	32.80M	40.90M	19.60M	9.80M
Gross Profit Ratio	47.46%	42.35%	40.50%	38.96%	38.59%	35.35%	34.21%	34.66%	32.37%	33.40%	32.41%	28.04%	-2.74%	24.10%	29.54%	35.33%	35.11%	37.85%	30.17%	27.29%	39.92%	50.28%	53.99%	35.64%	37.96%	45.24%	42.89%	40.83%
Research & Development	22.41M	59.06M	56.37M	46.94M	47.00M	51.54M	52.23M	52.65M	48.99M	47.46M	39.85M	31.16M	31.61M	42.92M	51.72M	70.67M	62.77M	67.13M	72.89M	75.06M	60.87M	42.95M	22.40M	22.70M	14.20M	12.40M	0.00	0.00
General & Administrative	0.00	241.14M	211.96M	167.02M	153.06M	130.26M	115.27M	111.10M	99.55M	110.16M	102.54M	85.60M	91.23M	110.52M	120.42M	141.03M	83.15M	96.77M	98.31M	101.21M	95.92M	70.86M	31.60M	26.50M	12.80M	12.40M	11.80M	6.50M
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	0.00	241.14M	211.96M	167.02M	153.06M	130.26M	115.27M	111.10M	99.55M	110.16M	102.54M	85.60M	91.23M	110.52M	120.42M	141.03M	83.15M	96.77M	98.31M	101.21M	95.92M	70.86M	31.60M	26.50M	12.80M	12.40M	11.80M	6.50M
Other Expenses	252.49M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	203.57M	0.00	0.00	3.10M	3.66M	44.61M	499.57M	30.19M	30.21M	10.40M	8.10M	4.80M	3.10M	1.20M	800.00K
Operating Expenses	274.90M	300.20M	268.33M	213.96M	200.07M	181.80M	167.50M	163.75M	148.54M	157.62M	142.39M	116.76M	122.84M	357.01M	172.14M	211.70M	149.02M	167.56M	215.81M	675.83M	186.97M	144.02M	64.40M	57.30M	31.80M	27.90M	13.00M	7.30M
Cost & Expenses	544.79M	817.45M	732.92M	599.44M	625.55M	544.05M	531.11M	479.26M	453.51M	503.59M	607.47M	543.44M	347.54M	756.55M	695.80M	659.79M	449.97M	503.01M	455.75M	897.04M	416.31M	303.68M	112.20M	121.60M	85.40M	77.40M	39.10M	21.50M
Interest Income	0.00	849.00K	1.45M	1.88M	464.00K	452.00K	899.00K	950.00K	1.03M	1.21M	1.15M	1.12M	2.72M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	-2.04M	2.94M	22.25M	9.52M	408.00K	157.00K	395.00K	202.00K	2.00K	14.00K	65.00K	80.00K	454.00K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	65.33M	65.50M	54.45M	37.43M	28.15M	28.05M	25.16M	23.46M	24.16M	21.62M	17.25M	18.42M	25.86M	34.54M	32.80M	33.90M	17.19M	18.38M	31.81M	38.03M	45.26M	30.21M	10.40M	8.10M	4.80M	3.10M	1.20M	800.00K
EBITDA	153.94M	143.23M	514.01M	116.27M	103.31M	34.54M	43.21M	53.04M	19.77M	35.14M	147.62M	74.74M	-200.91M	-200.18M	186.56M	64.56M	12.34M	44.15M	-149.04M	-589.11M	9.16M	55.72M	1.50M	-14.60M	5.20M	16.10M	7.90M	3.00M
EBITDA Ratio	29.97%	15.96%	65.83%	18.41%	14.91%	6.16%	7.82%	10.99%	4.38%	6.77%	21.45%	12.60%	-91.86%	-38.03%	25.10%	9.32%	2.66%	8.18%	-43.38%	-193.62%	2.40%	17.35%	1.44%	-14.61%	6.02%	17.81%	17.29%	12.50%
Operating Income	-28.87M	79.82M	47.93M	32.12M	67.34M	16.28M	21.60M	3.59M	-2.55M	15.86M	80.63M	49.54M	-128.83M	-230.18M	47.46M	33.08M	13.78M	36.76M	-112.14M	-592.79M	-34.59M	17.42M	-8.30M	-21.70M	1.00M	13.00M	6.60M	2.50M
Operating Income Ratio	-5.62%	8.90%	6.14%	5.09%	9.72%	2.90%	3.91%	0.74%	-0.57%	3.05%	11.72%	8.35%	-58.91%	-43.73%	6.39%	4.77%	2.97%	6.81%	-32.64%	-194.83%	-9.06%	5.43%	-7.99%	-21.72%	1.16%	14.38%	14.44%	10.42%
Total Other Income/Expenses	-20.10M	-4.85M	-38.49M	-11.66M	-1.97M	-12.32M	-3.79M	-5.29M	-4.21M	-4.44M	46.94M	6.53M	-98.08M	-5.97M	8.18M	-3.17M	-14.98M	-10.78M	-68.71M	-34.63M	-1.51M	8.08M	-600.00K	-1.00M	-600.00K	0.00	100.00K	-300.00K
Income Before Tax	-48.97M	74.97M	9.44M	20.47M	65.37M	3.95M	17.82M	-1.70M	-6.76M	11.42M	127.58M	56.06M	-226.92M	-236.15M	55.64M	29.91M	-1.20M	25.99M	-180.85M	-627.41M	-36.10M	25.51M	-8.90M	-22.70M	400.00K	13.00M	6.70M	2.20M
Income Before Tax Ratio	-9.53%	8.36%	1.21%	3.24%	9.43%	0.71%	3.22%	-0.35%	-1.50%	2.20%	18.54%	9.45%	-103.75%	-44.86%	7.49%	4.32%	-0.26%	4.81%	-52.63%	-206.21%	-9.46%	7.94%	-8.57%	-22.72%	0.46%	14.38%	14.66%	9.17%
Income Tax Expense	-20.10M	9.94M	-111.00K	-47.25M	12.14M	75.81M	3.43M	-1.98M	-2.17M	-123.28M	1.95M	-2.75M	643.00K	1.23M	2.29M	4.73M	5.20M	8.05M	4.91M	92.82M	-6.44M	12.75M	-1.00M	-4.30M	-400.00K	4.50M	2.10M	700.00K
Net Income	110.75M	64.85M	437.42M	116.58M	62.61M	-69.48M	14.22M	31.36M	-2.22M	136.79M	128.35M	58.98M	-227.86M	-235.95M	151.47M	25.93M	-10.06M	17.72M	-185.76M	-719.95M	-29.66M	12.75M	-7.90M	-18.40M	800.00K	8.50M	4.60M	1.50M
Net Income Ratio	21.56%	7.23%	56.02%	18.46%	9.04%	-12.40%	2.57%	6.50%	-0.49%	26.33%	18.65%	9.95%	-104.18%	-44.83%	20.38%	3.74%	-2.17%	3.28%	-54.06%	-236.63%	-7.77%	3.97%	-7.60%	-18.42%	0.93%	9.40%	10.07%	6.25%
EPS	1.49	0.88	6.04	1.64	0.90	-1.01	0.21	0.47	-0.03	2.10	1.99	0.92	-3.62	-3.66	2.06	0.36	-0.22	0.41	-5.05	-27.90	-1.65	0.84	-0.71	-1.79	0.09	1.04	0.72	0.32
EPS Diluted	1.49	0.88	6.04	1.64	0.89	-1.01	0.21	0.46	-0.03	2.08	1.97	0.92	-3.62	-3.66	2.04	0.36	-0.22	0.41	-5.05	-27.90	-1.65	0.78	-0.71	-1.79	0.09	1.04	0.72	0.32
Weighted Avg Shares Out	74.50M	73.85M	72.39M	70.94M	69.58M	68.51M	67.41M	66.65M	65.91M	65.13M	64.55M	63.78M	62.91M	64.54M	73.49M	72.32M	44.92M	43.01M	36.77M	25.81M	18.02M	15.22M	11.19M	10.27M	8.44M	8.20M	6.39M	4.69M
Weighted Avg Shares Out (Dil)	74.50M	73.85M	72.39M	70.94M	70.49M	68.51M	68.55M	67.64M	65.91M	65.72M	65.00M	64.17M	62.91M	64.54M	74.07M	72.53M	44.92M	43.47M	36.77M	25.81M	18.02M	16.35M	11.19M	10.27M	8.44M	8.20M	6.39M	4.69M

Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast

November 7, 2022prnewswire.com

CHELMSFORD, Mass. , Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes.

Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

August 30, 2022prnewswire.com

CHELMSFORD, Mass. , Aug. 30, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 20th Annual Global Healthcare Conference in New York City, on Tuesday, September 13, 2022, which includes a...

Azenta, the former Brooks Automation to begin trading under new ticker

December 1, 2021marketwatch.com

Azenta Inc. AZTA, -2.73% , formerly known as life sciences solutions company Brooks Automation Inc., said Wednesday that its stock will begin trading under a new ticker -- "AZTA" -- after the opening bell. The previous ticker was "BRKS.

Bear Of The Day: Brooks Automation (BRKS)

November 18, 2021zacks.com

Earnings estimates have dropped dramatically for this stock sending it to the lowest Zacks Rank

Brooks Automation (BRKS): $145 Price Target From B. Riley

November 18, 2021pulse2.com

The shares of Brooks Automation, Inc (NASDAQ: BRKS) have received a $145 price target from B. Riley. These are the details.

Brooks to Participate in Evercore ISI 4th Annual HealthCONx Virtual Conference

November 17, 2021prnewswire.com

CHELMSFORD, Mass., Nov. 17, 2021 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Evercore ISI 4th Annual HealthCONx Virtual Conference on Tuesday, November 30, 2021 which includes a webcast beginning at 2:40 p.m.